Avalo Therapeutics, Inc. (NASDAQ:AVTX) Receives $30.00 Average Price Target from Analysts
Shares of Avalo Therapeutics, Inc. (NASDAQ:AVTX – Get Free Report) have been given a consensus recommendation of “Buy” by the six brokerages that are covering the company, Marketbeat.com reports. Six equities research analysts have rated the stock with a buy recommendation. The average 1-year target price among brokerages that have updated their coverage on the […]
Shares of Avalo Therapeutics, Inc. (NASDAQ:AVTX – Get Free Report) have been given a consensus recommendation of “Buy” by the six brokerages that are covering the company, Marketbeat.com reports. Six equities research analysts have rated the stock with a buy recommendation. The average 1-year target price among brokerages that have updated their coverage on the […]
